NIKI
Niki BioSolutions Inc.
NIKI | NASDAQ
$1.77
-$0.19 (-9.51%)
At close: Oct 30, 2026, 4:00 PM ET
$1.70
-$0.07 (-3.95%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 431.38K | 1.3M | 1.54M | 911.51K |
Cost of Revenue | n/a | 255.05K | 420.81K | 1.22M | 1.46M | 1.02M |
Gross Profit | n/a | -255K | 10.57K | 80.07K | 81.85K | -104K |
Operating Income | -1.82M | -3.8M | -10.6M | -17.51M | -19.21M | -19.89M |
Interest Income | n/a | n/a | n/a | 146.59K | n/a | n/a |
Pretax Income | -1.38M | -4.16M | -4.34M | -11.53M | -27.11M | 4.92M |
Net Income | -1.36M | -4.27M | -2.83M | -9.8M | -25.05M | 7.07M |
Selling & General & Admin | 1.64M | 1.47M | 4.42M | 7.97M | 8.03M | 7.71M |
Research & Development | 352.88K | 1.94M | 5.2M | 9.22M | 10.87M | 11.59M |
Other Expenses | -170.76K | 128K | 999K | 68.95K | 392K | 877K |
Operating Expenses | 1.82M | 3.54M | 10.61M | 17.25M | 19.29M | 20.17M |
Interest Expense | 95.71K | 146.92K | 121.15K | n/a | 93.6K | 243.63K |
Selling & Marketing Expenses | n/a | n/a | 48.98K | 98.08K | n/a | n/a |
Cost & Expenses | 1.82M | 3.8M | 11.03M | 18.81M | 20.75M | 20.14M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 73.52K | 54.53K | 45.21K | 35.69K | 35.03K | 31.14K |
Shares Outstanding (Diluted) | 73.52K | 54.53K | 45.21K | 35.69K | 35.03K | 31.53K |
EPS (Basic) | -19 | -78 | -62 | -275 | -715 | 203 |
EPS (Diluted) | -19 | -78 | -62 | -275 | -715 | 200 |
EBITDA | -1.82M | -3.76M | -9.48M | -10.32M | -25.83M | 6.5M |
EBIT | -1.82M | -4.01M | -10.6M | -11.53M | -27.02M | 5.16M |
Depreciation & Amortization | n/a | 255.05K | 1.13M | 1.21M | 1.19M | 1.34M |
Add to Watchlist
Select watchlists to add or remove NIKI